CV #66(B): Health Authorities Fine With Vaccinating Pregnant Women, While Admitting No Testing Done

Bad medical advice is all too common. However, several “reputable” health authorities seem content to raise the stakes even more. They recommend — or at least don’t oppose — vaccinating pregnant women, despite openly admitting a serious lack of testing and longitudinal studies.

1. Who Are These “Reputable” Organizations?

  • World Health Organization
  • American Society of Obstetricians & Gynaecologists
  • U.S. Center for Disease Control
  • U.K. National Health Services
  • Royal College of Physicians of Ireland
  • Australian Department of Health
  • Canadian Society of Obstetricians & Gynaecologists

A disclaimer: this is certainly not all of them. More organizations could easily be added to this list.

2. World Health Organization

Should pregnant women be vaccinated?
While pregnancy puts women at higher risk of severe COVID-19, very little data are available to assess vaccine safety in pregnancy.
.
Nevertheless, based on what we know about this kind of vaccine, we don’t have any specific reason to believe there will be specific risks that would outweigh the benefits of vaccination for pregnant women.
.
For this reason, those pregnant women at high risk of exposure to SARS-CoV-2 (e.g. health workers) or who have comorbidities which add to their risk of severe disease, may be vaccinated in consultation with their health care provider.

The World Health Organization, or WHO, has very little data (or no data), concerning pregnant women and the risks of vaccination. Nonetheless, they don’t see a problem with this going ahead.

3. Society Of Obstetricians/Gynaecologists, US

-ACOG recommends that COVID-19 vaccines should not be withheld from pregnant individuals.
-COVID-19 vaccines should be offered to lactating individuals similar to non-lactating individuals.
-While a conversation with a clinician may be helpful, it should not be required prior to vaccination, as this may cause unnecessary barriers to access.
-Vaccines currently available under EUA have not been tested in pregnant women. Therefore, limited safety data specific to use in pregnancy is available. See details about the Food and Drug Administration’s (FDA) EUA process below.
Unfounded claims linking COVID-19 vaccines to infertility have been scientifically disproven.
-ACOG recommends vaccination for all eligible people who may consider future pregnancy.

It’s interesting that this group claims the link between COVID-19 vaccines and infertility has been scientifically disproved, considering they admit no testing has been done.

4. US Center For Disease Control

There are limited data about the safety of COVID-19 vaccines for people who are pregnant
Until findings are available from clinical trials and additional studies, only limited data are available on the safety of COVID-19 vaccines, including mRNA vaccines, administered during pregnancy:
.
Limited data are currently available from animal developmental and reproductive toxicity studies. No safety concerns were demonstrated in rats that received Moderna COVID-19 vaccine before or during pregnancy; studies of
-the Pfizer-BioNTech vaccine are ongoing.
-Researchers have studies planned in people who are pregnant.
-Both vaccine manufacturers are monitoring people in the clinical trials who became pregnant.

Getting vaccinated is a personal choice for people who are pregnant
.
People who are pregnant and part of a group recommended to receive COVID-19 vaccine, such as healthcare personnel, may choose to be vaccinated. A conversation between pregnant patients and their clinicians may help them decide whether to get vaccinated with a vaccine that has been authorized for use under Emergency Use Authorization (EUA). While a conversation with a healthcare provider may be helpful, it is not required prior to vaccination.

The U.S. Center for Disease Control (USCDC) shrugs off the vaccinating of pregnant women as a “personal choice”, despite there being no studies done on it. When they say “limited data”, it actually means that they have no data.

5. UK, National Health Services

COVID-19 vaccine in pregnancy
There is no known risk with giving inactivated virus or bacterial vaccines or toxoids during pregnancy or whilst breast-feeding. However, the COVID-19 vaccines have not yet been tested in pregnancy, so it has been advised that until more information is available, pregnant women should not routinely have these vaccines. As a matter of caution, COVID-19 vaccine is therefore not routinely advised in pregnancy but there are some circumstances in which the potential benefits of vaccination are particularly important for pregnant women. This may include women who are at very high risk of catching the infection or those with certain medical conditions that put them at high risk of suffering serious complications from COVID-19 infection. In such circumstances, a woman may choose to have COVID-19 vaccine in pregnancy following a discussion with her doctor or nurse.

Evidence so far reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulatory agency responsible for licencing medicines including vaccines, has raised no concerns for safety in pregnancy.

The data for each licensed COVID-19 vaccine in pregnancy is limited because pregnant women are not included in vaccine trials. This is not because of any specific safety concerns but as a matter of caution, like that applied to trials of most other medicines.

There is some deliberate word games here. The United Kingdown (Britain) tries to reassure the public that these vaccines are safe, while admitting that testing such as on pregnant women is non-existent. If no testing has been done, how can there be “limited evidence” available?

Also note: the UK doesn’t prohibit or recommend that pregnant women not be given this vaccine. Instead, they say that it shouldn’t COMMONLY be happening. Not the same thing.

6. Royal College Of Physicians Of Ireland

COVID-19 vaccines have not been studied in pregnancy and breastfeeding
.
You may get some side-effects from getting the vaccine.

What are the negatives of this option?
1. COVID-19 vaccines have not been studied in pregnant and breastfeeding people
We do not know for sure if there are negative impacts of giving COVID-19 vaccines in pregnancy.
However available information is reassuring and there are no current safety concerns about these vaccines in pregnancy.
2. You may get some side-effects from getting the vaccine.
Common side effects are reported in more than 1 in 10 people and include fatigue, headache, sore arm, fever and muscle or joint
pains. These are more common after the second dose and usually resolve within 2 days.

Despite not being tested on pregnant women, it is presented in Ireland as a serious option to consider. Considering all the hype about the health risks of this virus, this groups comes across indifferent as to the side effects of these injections.

7. Australian Department Of Health

How do I know that the COVID-19 vaccine is safe?
All vaccines are thoroughly tested for safety before they are approved for use in Australia. This includes careful analysis of clinical trial data, ingredients, chemistry, manufacturing and other factors.

Can I get the vaccine if I am pregnant?
In preparation for vaccine rollout, the Australian Technical Advisory Group on Immunisation (ATAGI) is currently finalising clinical advice for health care providers on the use of COVID-19 vaccines in Australia in 2021. This is likely to include advice in relation to pregnant women. This advice will be provided as soon as it is received.
.
Clinical trials for new medicines do not typically include pregnant or breastfeeding participants. Each country that is or has hosted clinical trials for COVID-19 vaccine candidates has different guidance regarding use of COVID-19 vaccines in pregnancy based on the benefits, risks and uncertainties in the context of the prevailing pandemic situation.

Australia claims it is still finalizing its guidance. Fair enough. However, the lack of testing on pregnant women should be a huge red flag for any advice that might come out in favour of this. But that isn’t really what they are saying.

8. Society Of Obstetricians/Gynaecologists, CA

Consensus Statement: Women who are pregnant or breastfeeding should be offered vaccination at any time during pregnancy if they are eligible and no contraindications exist.
.
This decision is based on the women’s personal values and an understanding that the risk of infection and/or morbidity from COVID-19 outweighs the theorized and undescribed risk of being vaccinated during pregnancy or
while breastfeeding
. Women should not be precluded from vaccination based on pregnancy status or breastfeeding.

Pregnant and breastfeeding women were excluded from the available Phase II and Phase III studies for the PfizerBioNTech and Moderna COVID-19 vaccines. However, for Pfizer-BioNTech, there were 23 individuals (12 in the vaccine arm and 11 in the placebo arm) who reported pregnancies during the trial and are being followed for pregnancy outcomes with no reports of adverse effects to date. For the Moderna trials, there were 13 women (6 in the vaccine and 7 in the placebo group) who reported pregnancies during the trial without report of adverse effects to date. Recently V-safe CDC registry which includes pregnant women reported no differences in the rates of adverse events or pregnancy complications for those women who were pregnant and received either the PfizerBioNtech vaccine or the Moderna vaccine. The Developmental and Reproductive Toxicity (DART) animal studies for the Moderna and Pfizer-BioNTech vaccines are ongoing. According to the World Health Organization (WHO) and the American College of Obstetricians & Gynecologists (ACOG), no major safety signals have been identified.

Similarly, breastfeeding women were also excluded from the Phase III trials available at present. Therefore, there is no data on the safety of COVID-19 vaccines in lactating women or the effects of mRNA vaccines on the breastfed infant or on milk production. Because mRNA vaccines are not considered live virus vaccines, they are not hypothesized to be a risk to the breastfeeding infant.

Pregnant and breast feeding women were not part of the AstraZeneca trials either. It seems that this piece of information should be front and center of any discussion or recommendation.

Decades of experience with other vaccines administered during pregnancy would suggest that we could expect a similar efficacy for the COVID-19 vaccines in pregnant women compared to non-pregnant women. Vaccines in general are immunogenic, safe, and efficacious when delivered to pregnant women. While there have been no red flags or hypothesized mechanisms for potential harm associated with the administration of an mRNA non-replicating viral vector vaccine during pregnancy, until more data is available, the potential risks of vaccination to a pregnant woman and her fetus remain unknown and only theoretical. What is known, however, is that an unvaccinated pregnant woman remains at risk of COVID-19 infection and remains at heightened risk of severe morbidity if infected compared to non-pregnant counterparts. Severe infection with COVID-19 carries risks to both maternal, fetal and neonatal health. While pregnancy itself does not appear to increase the risk of becoming infected with SARS-CoV-2, pregnant individuals may be in work-related (e.g., health-care worker, front line workers etc.) or community situations (e.g., caregiver, indigenous communities, outbreak setting, etc.) where the risk of infection is considerable. Owing to maternal age or underlying comorbidities, some pregnant women are at high risk of severe COVID-related morbidity.

So we don’t actually have any data on pregnant women being studied. But looking at OTHER vaccines, we assume the risk is similar.

NACI has advised “that a complete vaccine series with a COVID-19 vaccine may be offered to pregnant individuals in the authorized age group, without contraindications to the vaccine, if a risk assessment deems that the benefits outweigh the potential risks for the individual and the fetus, and if informed consent includes discussion about the absence of evidence on the use of COVID-19 vaccine in this population (Discretionary NACI Recommendation)”.

We recommend that pregnant and breastfeeding women who are eligible for the COVID-19 vaccine due to exposure risk, medical status, or other circumstances should be able to make an informed decision by having access to up-to-date information about the safety and efficacy of the vaccine (including clear information about the data that is not yet available) and information about the risks of COVID-19 infection for them. The concern around vaccination in the absence of evidence of safety in pregnancy has been debated in the literature. The PREVENT Working Group state, “the absence of evidence and the mere theoretical or even documented risk of fetal harm is generally not sufficient to justify denying pregnant women access to a vaccine in an outbreak or epidemic.” During an epidemic, the default should be to offer vaccines to pregnant women alongside other affected populations

Individuals contemplating pregnancy
For an individual planning a pregnancy, it is recommended to complete the entire COVID-19 vaccination series (where possible) to achieve maximal vaccine efficacy ahead of pregnancy. It is not known whether an individual should delay pregnancy following receipt of the vaccine and a risk-benefit discussion for those planning pregnancy should occur similar to the discussion for pregnant and breastfeeding women.

It’s recommended that women anticipating pregnancy get vaccinated first. Interesting. It seems that studies have been done on the reproductive problems, or possible sterility.

This entire article is filled with such nonsense. Pregnant women should be offered vaccination, however, the risks are downplayed, as is the lack of real testing. Also, it’s fair to assume that the overwhelming recovery rate of this “virus” is either minimized, or ignored entirely.

Section 30.1 of the Canada Food & Drug Act allows for the Health Minister to sign an Interim Order allowing untested vaccines to be approved. Public officials don’t discuss this. Nor do they mention the fact that they don’t do any testing; they just review the documentation.

In SOGC’s statement (see backup), they see nothing wrong with giving pregnant women — or nursing mothers — these “vaccines”. The reasoning behind it is convoluted and twisted.

These examples are hardly the only ones. However, it’s disturbing to see these seemingly legitimate organizations pushing vaccines on pregnant and nursing women — when they weren’t tested on them in the first place.

IMM #1(D): CANZUK Still Going Ahead, Despite “Global Pandemic”

Canada is supposedly in the middle of a deadly health crisis. One might expect there to be a push to close national borders to the greatest extent possible. Instead, it’s full speed ahead to the one-world order. See Part 1, Part 2 and Part 3.

1. Mass LEGAL Immigration In Canada

Despite what many think, LEGAL immigration into Canada is actually a much larger threat than illegal aliens, given the true scale of the replacement that is happening. What was founded as a European (British) colony is becoming unrecognizable due to forced demographic changes. There are also social, economic, environmental and voting changes to consider. See this Canadian series, and the UN programs for more detail. Politicians, the media, and so-called “experts” have no interest in coming clean on this.

CLICK HERE, for UN Genocide Prevention/Punishment Convention.
CLICK HERE, for Barcelona Declaration & Kalergi Plan.
CLICK HERE, for UN Kalergi Plan (population replacement).
CLICK HERE, for UN replacement efforts since 1974.
CLICK HERE, for tracing steps of UN replacement agenda.

Note: If there are errors in calculating the totals, please speak up. Information is of no use to the public if it isn’t accurate.

2. Offshoring, Globalization, Free Trade

The other posts on outsourcing/offshoring are available here. It focuses on the hidden costs and trade offs society as a whole has to make. Contrary to what many politicians and figures in the media claim, there are always costs to these kinds of agreement. These include: (a) job losses; (b) wages being driven down; (c) undercutting of local companies; (d) legal action by foreign entities; (e) industries being outsourced; (f) losses to communities when major employers leave; and (g) loss of sovereignty to foreign corporations and governments. Intellectual property also becomes a tricky issue. Don’t believe the lies that these agreements are overwhelmingly beneficial to all.

3. Important Links

James Skinner’s LinkedIn Page
https://archive.is/IZ7MB
Open Parliament, HoC Quotes, Speeches
CPC Adopts CANZUK In 2018 Party Convention
CANZUK’s Registry With Corporations Canada
CANZUK’s Information With Lobbying Registry
CANZUK And Health Care Challenges
CANZUK All Party Parliamentary Group

canzuk.01.directors.list
canzuk.02.articles.of.incorporation
canzuk.03.corporate.profile

4. CANZUK During (Alleged) Deadly Epidemic

For a bit of context, keep in mind that Covid-19 is supposedly a deadly disease that has caused untold death and misery across the planet. Now, it would seem counter-intuitive to promote the open borders agenda in the middle of it. However, that is exactly what is happening.

5. Who Is James Skinner, CANZUK Head?

  • Congressional Assistant (U.S.)
  • Parliamentary Adviser (Australia)
  • Parliamentary Adviser (U.K.)
  • Conservative Party of Canada

James Skinner is quite the varied political operative. It’s important to note that he was the Vice President of a Conservative Party of Canada EDA at the same time. Quite the conflict of interest.

Also, the politicians supporting CANZUK aren’t Liberals, they’re Conservatives. Skinner is using his political ties to push CPC policy towards open borders. Skinner is also an experienced lobbyist, and brings those skills to this project.

6. Bait-And-Switch #1: CANZUK V.S. UNGMC

In late 2018, the Conservative Party of Canada finally decided that it opposed the UNGMC, the United Nations Global Migration Compact. This was done just days before the agreement was scheduled to be signed. There were valid criticisms about “setting international standards” for migration.

However, this involves some serious mental gymnastics. CANZUK is literal open borders, and the CPC has that policy on its books. Worse, this would be legally binding, unlike the UN Compact.

7. Bait-And-Switch #2: Expand CANZUK Zone

This was addressed here. CANZUK is sold to the public as a free trade & open movement agreement between 4 countries. However, there are many, like Erin O’Toole, who support expanding it even further. Once it’s operational, open up to other countries.

8. Bait-And-Switch #3: When It Started

To begin with, the group was formed in 2015. The Above video of Erin O’Toole was from the 2018 CPC Policy Convention in Halifax. At that point, the Party officially adopted CANZUK. It is only AFTER this adoption that CANZUK International forms a Federal Corporation in Canada.

And it is only in the last few months that there is any “official” lobbying done on behalf of the organization. The order seems completely backwards.

The only way this makes sense is that it was all agreed to — behind closed doors — long before anything official was put into writing.

9. Bait-And-Switch #4: Countering China

Here’s another sleight of hand going on: CANZUK is currently being sold as a way to counter growing Chinese influence. This is nonsense, as CANZUK is not any sort of military agreement, simply trade and movement. Moreover, since O’Toole still supports high levels of Chinese immigration and trade, it’s unclear what he expects to accomplish.

Got to admire the nerve. The CPC pushed for FIPA, which allowed China almost unfettered access into Canada. It was sold as an investment protection initiative, and an increase in trade. Now that Canadians want less to do with China, CANZUK is sold as a way to counter China increasing global influence.

10. Bait-And-Switch #5: Healthcare Boost

Remember the panic over empty shelves of toilet paper or the sudden drug prescription limit of 30 days? Now imagine an alliance that would have allowed us to be better prepared to handle this crisis.

The COVID-19 pandemic has highlighted numerous gaps in our healthcare systems, be it issues of equity and access as evidenced by the disproportionately affected visible minorities or the inadequate security of our supply chains. The disruptions in personal protective equipment (PPE), lack of adequate testing and drug shortages have been sources of stress for frontline workers, healthcare managers and patients alike.

Our healthcare services are perennially underfunded and overstretched: the pandemic has laid bare our vulnerabilities to physician shortages, high rates of infection (nearly 20 per cent as of September 2020) among healthcare workers, increased healthcare costs, worsening mental health, and chronically underfunded long-term care. Furthermore, the pandemic has demonstrated the lack of an effective international crisis-management system. With global and national realignments the need of the hour, CANZUK is an idea whose time has come.

Remember people buying out all the toilet paper last year? Well, guess what? If we had more open borders, with more free trade, that likely wouldn’t have happened. In fact, things would have been a lot better off. Forget about closing borders in a crisis.

11. Bait-And-Switch #6: No Global Crisis

One would think that in the middle of a so-called “global pandemic” that open borders ideas like CANZUK would be put on the backburner, at least for the foreseeable future. Nope. Instead, there is scarcely a mention. Funny, how that works out. It’s almost like there really is nothing serious to worry about.

In fact, scrolling through CANZUK’s many articles, there’s barely a mention at all.

Different excuses. Different lies. But the open borders agenda rolls on.

CV #30(B): Pfizer Still Lobbying In Canada, Vaccine Approved In U.K.

Vaccines are coming into Canada from Pfizer and others. This was recently been announced on the CBC. For some context, remember that:
-The virus survival rate is over 99%
-PCR tests are useless as diagnostic tools
-People have to be tested to know they have it
-Vaccines were cooked up in the last few months, side effects unknown
-Things like masks will continue afterwards

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes, obscuring the vile agenda called the “Great Reset“. The Gates Foundation finances: the WHO, the US CDC, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the BBC, and individual pharmaceutical companies. Also: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations are legally binding. See here, here, and here. The media is paid off, and our democracy compromised, shown: here, here, here, and here.

2. Important Links

Pfizer’s Vaccine Promoted On CBC News
Lobbying Commissioner’s Office In Canada
Lobbying Registry Of Ontario
Manitoba Provincial Lobbying Registry
Alberta Lobbyist Registry
Pfizer Lobbying The Federal Government On Vaccines
Goldy Hyer Ex-Pfizer Lobbyist In Ottawa
Goldy Hyer’s LinkedIn Page
M-132, Parliamentary Study On International Vaccines
Section 30.1 Of Canada Food And Drug Act
Interim Order Allowing CV Vaccines To Be Sold In Canada

UK To Allow Certain Vaccines Deployed In Country
https://archive.is/wTXun
CV-19 To Be Added To UK Vaccine Compensation Scheme
https://archive.is/fHGKZ

GSK Indemnified Against Damages For H1N1 Vaccines In 2009
Pfizer Clinical Information
Pfizer And Violation Tracker Documentation

3. Rempel Isn’t Who She Pretends To Be

In the video with Michelle Rempel-Garner (discussing Derek Sloan’s petition), it’s interesting that she shrugs off the very valid concerns of unproven drugs. She also doesn’t question the wisdom behind lockdowns themselves. Want your freedom? Shut up and get the vaccine. This is typical of “conservative” politicians in Canada.

Rempel isn’t who she appears to be. And why exactly does she keep looking to her right in the video? Is there someone else in the room?

4. Pfizer Lobbying Ottawa Regularly

Pfizer has lobbied the Federal Government 153 times since becoming a registered lobbyist in 2007. Of course, that doesn’t include any discussions that may be “off the books”. One of Pfizer’s lobbyists, Steven Hogue, used to work in the Prime Minister’s Office when Jean Chretien was in office.

5. Goldy Hyer Ex-Pfizer Lobbyist In Ottawa

Goldy Hyer was at a time the Chief-of-Staff for Joe Clark, then Leader of the Progressive Conservative Party of Canada. He is also involved with:
(a) The Century Initiative
(b) Asia Business Leaders Advisory Council
(c) Catalyst Inc. / Catalyst Canada
(d) 30% Club Canada

6. Pfizer Lobbied M-132 Committee Vice-Chairs

Motion Text
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted.

M-132 was filed in late 2017, by Raj Saini. It was a motion to finance pharmaceuticals, and pharmaceutical research, both in Canada and abroad. See here and here. Marilyn Gladue, and Don Davies, (both lobbied by Pfizer), were the Vice-Chairs on that Committee.

7. Pfizer Lobbying In Ontario

Pfizer has also been busy lobbying Ontario since 2002 over pharmaceutical interests. It’s worth noting, that both Kathleen Wynne and Doug Ford never fully implemented Bill 160. This Bill would have mandated disclosure, (rather than it being optional), of payments made to health care providers to sell certain drugs.

Since Bill 160 isn’t really the law, there’s no requirement hospitals or health care staff to disclose the financing they may get to push certain remedies.

8. Pfizer Lobbying In Manitoba

Manitoba has had lobbyists from Pfizer in the past, but none active since 2017. Perhaps they have moved on to Ottawa.

9. Pfizer Lobbying In Alberta

A search in the Alberta Lobbyist Registry shows 12 meetings since 2018 between Government officials, and Pfizer. The last one was just the other day. Jason Kenney isn’t doing quite the “hard sell” that Ford does, but he is still fully on board with the agenda.

Of course, there is other lobbying going on, and in other Provinces as well. These examples provided are hardly exhaustive of what’s going on, but should provide a decent sample.

10. Hajdu Order To Approve Untested Vaccines

Interim Orders
Marginal note:Interim orders
.
30.1 (1) The Minister may make an interim order that contains any provision that may be contained in a regulation made under this Act if the Minister believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment.
.
Marginal note: Cessation of effect
.
(2) An interim order has effect from the time that it is made but ceases to have effect on the earliest of
.
(a) 14 days after it is made, unless it is approved by the Governor in Council,
.
(b) the day on which it is repealed,
.
(c) the day on which a regulation made under this Act, that has the same effect as the interim order, comes into force, and
.
(d) one year after the interim order is made or any shorter period that may be specified in the interim order.

On September 16, 2020, Health Minister Patty Hajdu signed an Interim Order allowing for approval of vaccines in an expedited manner, even if they were fully tested. Section 30.1 of the Food and Drug Act allows that. It must be pointed out, however, that Hajdu is not a doctor, and has no medical background at all.

11. UK Approves Pfizer/BioNTech Vaccine, Dec. 2

Tens of thousands of people will receive an effective and high-quality COVID-19 vaccine from next week, as the UK becomes the first country in the western world to authorise a vaccine.

Following rigorous clinical trials involving thousands of people and extensive analysis of the vaccine’s safety, quality and effectiveness by experts from the Medicines and Healthcare products Regulatory Agency (MHRA), Pfizer/BioNTech’s vaccine has been authorised for use in the UK.

Now authorisation has been granted, Pfizer will deliver the vaccine to the UK. In making the recommendation to authorise supply, the MHRA will decide what additional quality assurance checks may be required before a vaccine can be made available. Pfizer will then deliver the vaccines to the UK as soon as possible.

The NHS has decades of experience in rolling out successful widespread vaccination programmes and has put in place extensive deployment plans.

In line with the recommendations of the independent Joint Committee for Vaccination and Immunisation (JCVI), the vaccine will be rolled out to the priority groups including care home residents and staff, people over 80 and health and care workers, then to the rest of the population in order of age and risk, including those who are clinically extremely vulnerable.

Isn’t this great? Pfizer/BioNTech got their approval to start distributing vaccines in the UK. Surely, with all these rigorous tests, they are certain that the product is safe, right?

12. UK: Vaccine Damage Payments Scheme

In advance of a rollout of an authorised COVID-19 vaccine and in line with other immunisation programmes, the government is taking the precautionary step to ensure that, in the very rare possibility where someone is severely disabled as a result of taking a COVID-19 vaccine, they can access financial assistance through the Vaccine Damage Payments Scheme (VDPS).

No safety concerns have been reported in vaccines authorised for use following rigorous clinical trials involving tens of thousands of people and extensive analysis of the vaccine’s safety, quality and effectiveness by experts from the Medicines and Healthcare products Regulatory Agency (MHRA).

Pfizer/BioNTech’s vaccine is now the first COVID-19 vaccine to be authorised for use in the UK, and the MHRA will keep safety under continual review.

Adding diseases to the VDPS is not new and numerous diseases have been added as successive governments have rolled out more immunisation programmes, such as HPV and Meningitis B. In response to the H1N1 (swine flu) pandemic, the previous government added swine flu to the VDPS on 10 October 2009.

Generally, only those who were administered vaccines as part of a childhood immunisation programme are covered under the VDPS. However, because COVID-19 vaccines will be rolled out to a large proportion of the adult population, the government will amend the eligibility requirements, ensuring adults who are administered a COVID-19 vaccine in the UK or Isle of Man, or as part of an armed forces medical treatment, will be covered by the scheme too.

The VDPS is a safety net to help ease the burden on individuals who have in extremely rare circumstances experienced harm due to receiving a government-recommended vaccine. It is not a compensation scheme. Rather, it provides a one-off, tax-free lump sum – currently £120,000 – for those suffering a severe disability as a result of a vaccine against a disease listed under the Vaccine Damage Payments Act.

Background information
Currently, in order to qualify for the payment, it must be accepted, on the balance of probability, that there is a causal link between the vaccine and the claimed disability and that the resulting disability amounts to severe (ie at least 60%) disablement.
.
Claims are assessed and paid where successful by the Department for Work and Pensions.

The UK Government only the day before announces approval for Pfizer/BioNTech’s vaccine. Almost immediately afterwards, the UK reveals that taxpayers will be on the hook for any injuries that result from these vaccines.

The amount is capped at £120,000, and even then, it’s only with very serious disability. Capitalized profits, socialized compensation. Of course, the implication of having a vaccine compensation scheme means that the companies themselves will be off the hook for whatever death and injury results.

13. Pfizer And Violation Tracker

Of course, Pfizer isn’t too willing to share some of it’s more troubling history, such as this provided by Violation Tracker. Well worth a long read. Everything from false claims, to bribery, to kickbacks are cited.

14. Gates A Recent Pfizer Donor

In addition to making contributions to Pfizer, the Bill & Melinda Gates Foundation owns over $1.7 million in stock from the pharmaceutical company.

BILL & MELINDA GATES FOUNDATION
EIN: 56-2618866
gates.foundation.taxes.2016
gates.foundation.taxes.2017
gates.foundation.taxes.2018

BILL & MELINDA GATES FOUNDATION TRUST
EIN: 91-1663695
gates.foundation.trust.taxes.2018

Take a look at the documents for yourself. The full list can be found here, just search for the Bill & Melinda Gates Foundation. Those 2 organizations will pop up.

The above screenshots are donations the Gates Foundation made in 2016 and 2018.

15. Pfizer Vaccines Coming To Canada/U.S.

Pfizer has already applied for permission to begin distributing in Canada and the United States, and they very likely will get it. If it’s anything like what happened with GlaxoSmithKline, they’ll be indemnified as well. Even if Canada were to set up a compensation scheme, it will never fully make up for the harm done.

And this point is critical: the vaccines haven’t even been fully tested. They’ll be doing more long term studies as the years go on. This is not the same thing as having vaccines ready.

As Tam says: vaccines normally take a decade or more. But here, just a few months apparently. And all for something with a mortality rate approximately that of the flu.

What about long term problems like premature death? Sterilization? Paralysis? Pain? Disfiguration? Unfortunately, a lot of that won’t become clear for a few years at least. Consequently, people will have to hope and pray.

CV #35(B): Deja Vu? Parallels With 2009 H1N1; Ferguson; PCR; Limited Trials; Indemnification

“The Minister may make an interim order that contains any provision that may be contained in a regulation made under this Act if the Minister believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment.” Section 30.1(1) of the Food and Drugs Act. Sure, there are standards, but they can be bypassed if needed.

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes, obscuring the vile agenda called the “Great Reset“. The Gates Foundation finances: the WHO, the US CDC, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the BBC, and individual pharmaceutical companies. Also: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations are legally binding. See here, here, and here. The media is paid off, and our democracy compromised, shown: here, here, here, and here.

2. Important Links

Imperial College London Modelling H1N1
https://archive.is/KLgV2
Imperial College London’s Findings On Swine Flu (H1N1)
https://archive.is/gj4R6
CDC Approves PCR Tests For H1N1 Detection
Interim Order Allowing H1N1 Vaccine
[A] Q&A About Vaccine Arepanrix H1N1 Approval
[A] Information About Research Performed
https://archive.is/WskgA
[B] Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine
https://archive.is/wip/q1Z79
Food & Drug Act Of Canada
Adam v. GlaxoSmithKline Inc., 2019 ONSC 7066 (CanLII)
2010 Film: Outbreak, Anatomy Of A Plague
Rockefeller.Foundation.lockstep.2010

Order In Council: 2009-1769
Order In Council: 2009-1857

3. Neil Ferguson’s Shoddy Modelling

Neil Ferguson and Imperial College London were also involved in modelling H1N1 (Swine Flu), over a decade ago. His models are about as off the mark then as they are now.

Imperial College London has financial ties to the Bill & Melinda Gates Foundation. Gates himself shows interest in many of ICL’s activities.

Professor Neil Ferguson, the corresponding author of the new research from the MRC Centre for Outbreak Analysis and Modelling at Imperial College London, said: “Our study shows that this virus is spreading just as we would expect for the early stages of a flu pandemic. So far, it has been following a very similar pattern to the flu pandemic in 1957, in terms of the proportion of people who are becoming infected and the percentage of potentially fatal cases that we are seeing.

“What we’re seeing is not the same as seasonal flu and there is still cause for concern – we would expect this pandemic to at least double the burden on our healthcare systems. However, this initial modelling suggests that the H1N1 virus is not as easily transmitted or as lethal as that found in the flu pandemic in 1918,” added Professor Ferguson.

Even back in 2009 (and in fact earlier), Ferguson was quite willing to push the panic button based on very incomplete information. It must be noted that models are not proof or evidence, they are merely predictions. These predictions are subjected to the same limitations and biases of the people conducting them.

Ferguson’s “models” predicted some 65,000 deaths in the U.K. as a result of Swine Flu. A total of 457 materialized in the end. And it’s just one of the times he’s grossly overshot the mark.

4. PCR Tests Used For Swine Flu Detection

This guidance was revised to clarify that the current rRT-PCR developed by CDC to detect novel influenza A ( H1N1) is authorized by the FDA. The FDA authorization, also termed Emergency Use Authorization or EUA, is not equivalent to FDA cleared, which was incorrectly stated in the previous version of the guidance.

Those PCR tests (which don’t detect Covid-19), were also approved for use in diagnosing H1N1 by the Center for Disease Control in the U.S. The technology wasn’t suited then, and isn’t now.

5. Inadequate Clinical Trials: (Arepanrix H1N1)

4. What evidence was used to support the authorization of Arepanrix™ H1N1?
A prototype or “mock” vaccine was developed in the pre-pandemic period using another strain of influenza virus, the H5N1 strain. During this period Health Canada inspected the vaccine manufacturing facilities, validated the vaccine production process, and reviewed results from both animal and human studies with the mock vaccine. In addition, the safety and effectiveness of the adjuvant to be used with the vaccine was assessed by Health Canada. Once the H1N1 virus emerged as the pandemic virus, the manufacturer initiated vaccine production using the strain recommended by the WHO.

5. What are the benefits and potential risks associated with Arepanrix™ H1N1?
Criteria have been established to assess the immunogenicity of vaccines. Clinical trial results indicate that Arepanrix meets all of these criteria, which means that the vaccine produces an adequate level of protection against the H1N1 pandemic virus.
.
As with all medicinal products, there may be side effects or adverse events associated with the use of the product. Some of the very common adverse events that have been observed in clinical trials with the pandemic vaccine include pain at the injection site, fatigue, headache, swollen glands in the neck, joint pain, and muscle ache. Refer to the product leaflet for additional information on adverse events.

6. How was Arepanrix™ H1N1 authorized?
Arepanrix™ H1N1 was approved because it was shown that the benefits of the vaccine outweigh any risks. The time frame between vaccine manufacturing and the need to use the vaccine in time to provide the public with protection against the virus is very short. As a result, it has not been possible for the manufacturer to collect the usual full information necessary for a Notice of Compliance to be issued under the Food and Drug Regulations. For this reason, an Interim Order was used to provide an alternate pathway to allow for the authorization for sale of the vaccine. Under the Interim Order, the manufacturer is required to continue submitting data on the safety and effectiveness of the vaccine. Health Canada and the Public Health Agency of Canada will review this information as it becomes available.

This vaccine was rushed out for use in the general population. This was despite the testing not being complete. The Minister of Health signed an interim Order allowing it to be dispensed anyway.

It’s worth pointing out that initial trials were not even conducted on the H1N1 influenza strain, but on another one. Fair to ask how valid that initial research would be.

Elderly (>60 years):
There are limited data available from clinical studies with Pandemrix™ (H1N1) and with Arepanrix™ H1N1 vaccine in adults aged over 60 years.
.
The recommended dosage for this age group is one dose of 0.5mL.
.
Immunogenicity data obtained at 3 weeks after administration of Pandemrix (H1N1) or Arepanrix™ H1N1 in clinical studies in this age group suggest that a single dose may be sufficient.
.
If a second dose is administered, it should be given after an interval of at least three weeks. See section Pharmacodynamics.

Children and adolescents aged 10-17 years:
No clinical data are available for Arepanrix™ H1N1 in this age group. There are limited data available from a clinical study with Pandemrix™ (H1N1) in this age group.
.
The recommended dosage for this age group is in accordance with recommendations for adults.

Children aged from 6 months to 9 years:
One dose of 0.25mL (i.e. half of the adult dose) at an elected date.

Preliminary immunogenicity data obtained in a limited number of children aged 6-35 months who received two doses of 0.25 mL of Pandemrix™ (H1N1) containing 1.9 µg HA derived from A/California/7/2009 (H1N1) and a limited number of children aged 3-9 years who received one dose of 0.5 mL of Pandemrix™ (H1N1) show that a good immune response is elicited after the first dose, but there is a further immune response to a second dose of 0.25 mL administered to children aged 6-35 months after an interval of three weeks.

Extremely limited studies were done prior to getting interim approval from the Minister of Health. In some cases, they were using different vaccines and working with different strains. Not really an apples to apples comparison.

6. Inadequate Trials: (Monovalent Vaccine)

Elderly (>60 years):
No clinical data are available for Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) in this age group. One dose of 0.5mL may be administered at an elected date.

Children and adolescents aged 10-17 years:
No clinical data are available for the Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) in this age group. One dose of 0.5mL may be administered at an elected date.

Children aged 3-9 years:
No clinical data are available for the Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) in this age group. The use of this vaccine should be considered in light of PHAC recommendations for the A/California/7/2009(H1N1)v-like vaccination. Preliminary data with other similar unadjuvanted vaccines suggest that if used in this age group, a 2-dose regimen (0.5mL with an interval of at least 21 days between doses) is recommended.

Children aged from 6-35 months:
No clinical data are available for the Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) in this age group. The use of this vaccine should be considered in light of PHAC recommendations for the A/California/7/2009(H1N1)v-like vaccination. Preliminary data with other similar unadjuvanted vaccines suggest that for this age group, unadjuvanted vaccine may not be suitable against this pandemic strain.

Children aged less than 6 months:
Vaccination is not currently recommended in this age group.
For further information, see section Pharmacodynamics.

This isn’t selective editing or anything of the sort. Health Canada approved the use of this drug for children between 6 months and 17 years, and over the age of 60, without there being clinical data to support that it worked. This is chilling to read.

7. Approval Of Experimental Drugs

“The Minister may make an interim order that contains any provision that may be contained in a regulation made under this Act if the Minister believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment.” [from the Food and Drugs Act]

That is Section 30.1(1) of the Food and Drug Act of Canada. It was used to approve 2 vaccines without full and complete trials. They were:
[1] Arepanrix™ H1N1 (AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine)
[2] Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant)

The Minister has the discretion to do this. And it happened, despite there not being adequate testing done. Could the same thing happen with Covid-19?

8. Indemnification From The Courts

Adam, Abudu v. Ledesma-Cadhit et al, 2014 ONSC 5726 (CanLII)
Adam v. GlaxoSmithKline Inc., 2019 ONSC 7066 (CanLII)

There are actually 2 different rulings based on vaccine injury from GlaxoSmithKline. Here are quotes from the later ruling.

[15] In early 2009, the WHO became aware of the development of a new strain of influenza virus: H1N1, commonly known as swine flu. It had not been seen in human populations before, as a result of which humans had no built up immunity. The WHO declared H1N1 to be a pandemic.

[16] On June 11, 2009, the WHO declared a phase 6 pandemic. This is the final and most serious stage of a pandemic. It marks sustained human-to-human transmission of the virus in more than one region of the world. By early July there had been 94,512 reported cases and approximately 429 recorded deaths attributable to H1N1.

[17] In the summer of 2009, the WHO called for manufacturers to begin clinical trials for a vaccine to combat H1N1.

[18] GSK developed two vaccines to combat H1N1: Arepanrix and Pandemrix. Both are substantially similar. Pandemrix was manufactured and distributed in Europe. Arepanrix was manufactured and distributed in Canada. Clinical trials for Arepanrix began in 2008 but had not been completed when the pandemic was declared.

[19] The federal Minister of Health authorized the sale of the Arepanrix vaccine pursuant to an interim order dated October 13, 2009. Human trials of the vaccine were still underway. The Minister of Health is empowered to make interim orders if immediate action is required because of a danger to health, safety or the environment. In issuing the interim order, Health Canada deemed the risk profile of Arepanrix to be favourable for an interim order. The authorization was based on the risk caused by the current pandemic threat and its danger to human health. As part of the interim order process, Health Canada agreed to indemnify GSK for any claims brought against it in relation to the administration of the Arepanrix vaccine.

[20] Although human trials of Arepanrix were not finished by the time Health Canada authorized its use, the vaccine was not without clinical history.

[34] The plaintiffs’ principal allegation with respect to the standard of care is that GSK failed to make adequate disclosure of the risks involved with Arepanrix.

[35] The plaintiffs began their challenge about disclosure with the evidence of Ms. Hyacenth who testified that she was not told that: (i) the vaccine had not been tested through the usual route, (ii) the vaccine had been subject to a hastened approval process by Health Canada, (iii) adjuvants had never been used in children, (iv) the Government of Canada was indemnifying the vaccine manufacturer; and (v) some countries refused to make the vaccine available because of safety concerns. Ms. Hyacenth says that had she been told about these things she would not have risked having her children vaccinated.

[36] Part of the challenge of the plaintiffs’ inadequate disclosure case is that Ms. Hyacenth was not the direct purchaser of the vaccine. Vaccines are administered through a “learned intermediary,” in this case, her family physician. The issue is significant because any disclosures GSK makes are made in product monographs or inserts that accompany each vial of vaccine. The patient getting the vaccine does not receive the box containing the vaccine and whatever disclosure document it contains. It is the physician who receives this.

[37] GSK did disclose in its Product Information Leaflet for the Arepanrix vaccine and in its product monograph that Health Canada had authorized the sale of the vaccine based on only limited clinical testing and no clinical experience at all with children. Dr. Ledesma-Cadhit believes she knew this from the Health Canada website. She was also aware that Arepanrix was authorized through a special process because of the pandemic.

[38] The product monograph for Arepanrix disclosed that there was limited clinical experience with an investigational formulation of another adjuvanted vaccine but no clinical experience with children. In addition, the product information leaflet and product monograph disclosed a number of risks.

In short, Health Canada approved a vaccine that in which trials were still ongoing. The doctor, despite reading the lengthy disclaimer, injected it, and this comes in spite of there being no trials on children.

The Canadian Government had agreed to indemnify the manufacturer, GSK, ahead of time. Moreover, the victims didn’t buy the product from the manufacturer, but from the doctor, a “learned intermediary”. In short, GlaxoSmithKline was legally off the hook for what it sold to the public.

Can we expect the same sort of thing here with Covid-19? Will the Government approve a vaccine (or multiple vaccines), that haven’t properly been tested, and indemnify the manufacturers? After all, the patients aren’t buying directly from the manufacturer, but are getting it from their doctors.

Moreover, doctors are largely immune from action against them if they are following approved practices. In this case, it would be administering drugs that Health Canada approved.

GSK has been registered as lobbying the Federal Government since 1996, and there are hundreds of communications reports. But getting an indemnification agreement was probably just a coincidence.

9. Strange Events Happened In 2010

The next year, Tam would go on to have an appearance in the movie “Outbreak: Anatomy Of A Plague”. She advocated locking people up and putting tracking bracelets on them. Quite the bit of predictive programming.

Rockefeller.Foundation.lockstep.2010

The infamous “Lockstep Narrative” was also written in 2010. That was just one scenario laid out in the infamous paper, but it largely parallels what’s happening today.

10. History Repeating Itself In 2020?

This may seem a bit hyperbolic, but what is going on in 2009 with Swine Flu closely parallels what is happening Covid-19. Main points include:

-Neil Ferguson and Imperial College London
-Useless PCR tests to detect viral infection
-Vaccines not fully tested
-Health Canada approves despite incomplete tests
-Vaccine manufacturers are indemnified

There are some differences though. The World Economic Forum wasn’t touting the “Great Reset”, and communist movements weren’t nearly as overt as today. Or perhaps that was all just setting it in motion.

Green New Deal Group, Taking Lessons From The 2008 Banking Bailout

Think recent public efforts to convince the public to act on climate change just happened? No, they are the result of years of planning, and from an organization called Green New Deal Group.

There is some real strategy at play here. Divert people’s attention with protests, riots, and public movements, and the agenda can be quietly passed. After all, how much coverage do the various treaties we sign (and bills we pass), actually get?

1. More On The International Banking Cartel

For more on the banking cartel, check this page. The Canadian Government, like so many others, has sold out the independence and sovereignty of its monetary system to foreign interests. BIS, like its central banks, exceed their agenda and try to influence other social agendas. See who is really controlling things, and the common lies that politicians and media figures tell. Now, the bankers work with the climate mafia and pandemic pushers to promote their mutual goals of control and debt slavery.

2. Debunking The Climate Change Scam

The entire climate change industry, (and yes, it is an industry) is a hoax perpetrated by the people in power, run by international bankers. Plenty has also been covered on the climate scam, the propaganda machine in action, and some of the court documents in Canada. Carbon taxes are just a small part of the picture, and conservatives are intentionally sabotaging their court cases.

3. Important Links

Green New Deal Group Main Page
https://archive.is/ncRvA
WayBack Machine Archives

About Us: Green New Deal Group
https://archive.is/rxRpv
WayBack Machine Archive

https://greennewdealgroup.org/2008/04/
Guardian 2008: We Wanted A Green New Deal
https://greennewdealgroup.org/2008/07/
Guardian 2008 Article On The Triple Crunch
https://greennewdealgroup.org/2009/03/
Gordon Brown Calls For Global Green New Deal
https://greennewdealgroup.org/2009/07/
The Ecologist: Bailed Out Banks Should Fund GND
Green New Deal Group Budget Proposal
Network For Greening The Financial System

AOC: This Is Our World War II
Mr. Reagan: The Brains Behind AOC
NBC On Sunrise Movement

4. About Green New Deal Group

As in past times of crises, disparate groups have come together to propose a new solution to an epochal challenge. The Green New Deal Group drew inspiration from the ambition of President Roosevelt’s comprehensive response to the Great Depression to propose a modernised version, a ‘Green New Deal’ in 2008. It was designed to kick start a rapid transition to a new economy shaped to prevent a climate breakdown and transform a failed financial system. The Green New Deal will power a renewables revolution, create thousands of green-collar jobs across the economy and rein in the distorting and socially-destructive power of the finance sector while making more low-cost capital available for pressing priorities.

Meeting since early 2007, the membership of the Green New Deal Group is drawn to reflect a wide range of expertise relating politics and economics, and the climate, nature and inequality crises. The views and recommendations of the Green New Deal series of reports, are those of the group writing in their individual capacities.

The Green New Deal Group is, in alphabetical order:
.
Larry Elliott, Economics Editor of the Guardian, Colin Hines, Co-Director of Finance for the Future, former head of Greenpeace International’s Economics Unit, Jeremy Leggett, founder and Chairman of Solarcentury and SolarAid, Clive Lewis, Labour MP, Caroline Lucas, Green Party MP, Richard Murphy, Professor of Practice, City University, Director Tax Research LLP, Ann Pettifor, Director, Policy Research in Macroeconomics (PRIME), Charles Secrett, Advisor on Sustainable Development, former Director of Friends of the Earth, Andrew Simms, Co-Director, New Weather Institute, Coordinator, The Rapid Transition Alliance, Assistant Director, Scientists for Global Responsibility. Geoff Tily Senior Economist, TUC

Those are the people who make up the Green New Deal Group. In essence, this is the brainchild behind the eco movement in recent years.

5. GNDG Used To Reboot After 2008 Crash

In the coverage of the causes and likely future effects of the credit crunch, such grim parallels are becoming commonplace. But it’s now time to move from problems to solutions, and here too the Depression can form a useful reference point. Franklin Roosevelt’s action programme for dealing with the aftermath of the late 1920s credit crunch was threefold: first, strictly regulate the cause of the problem – the greedy and feckless finance sector; second, get people back to work, and generate business opportunities by a New Deal. This invested billions of dollars in training, better working conditions and a huge range of infrastructural projects such as highways, dams and bridges. Finally, fund this in part by an increase in taxes on big business and the rich – a measure which also had the positive effect of dramatically decreasing inequality.

Today the re-regulation of finance is even being discussed among consenting free market adults in the columns of the Financial Times. My colleague, environmentalist Colin Hines, has fleshed out the details of a Green New Deal which could help re-boot the economy after the credit crash, while putting serious money into addressing climate change.

As a result of the 2008 crash, this group decided that it would make a great opportunity to completely remake their economy, and deal with climate change in the first place. They reasoned that if banks were worth pouring trillions into, then the environment must be as well. The argument does have some merit to it.

Notice that it’s compared to the “New Deal” that Franklin Delano Roosevelt launched in the 1930s. This is not the last time that comparison will come up.

Alexandria Ocasio-Cortez introduced the U.S. public to the Green New Deal in 2019, just after taking office. It wasn’t some brainstorm she had, but had been drawn up many years ago. The YouTuber, Mr. Reagan, did address that AOC was a puppet, but he missed how far back the plan went.

6. GND Group To Solve “Triple Crunch”

Can I trust the bank to look after my money? Clickety clack. How much has my house fallen in value? Clickety clack. Will high fuel prices mean I can’t keep my car on the road? Can I afford to buy enough food for the family? Clickety clack. Will I lose my job, and why is everyone making me paranoid about climate change when there’s nothing I can do about it? Clickety, clickety clack … and then back to the beginning. The “triple crunch” of a credit-fuelled financial crisis, accelerating climate change and soaring energy prices – how did we get into this mess? In the face of so many simultaneous crises, we all have legitimate questions for the governments that allowed us to sleepwalk into this situation.

The Green New Deal was dreamed up as a way to solve multiple problems, such as: (a) financial crisis; (b) climate change; and (c) energy prices all at once.

While it’s nice to see the financial crisis addressed, this group seems to miss the elephant in the room: central banking. It’s that the Government legislates in such a way that the U.S. is forced to borrow — at interest — from the Federal Reserve, a private organization. Do they not know about any of this?

7. History Of The Green New Deal

Where the Green New Deal came from
.
The idea of a Green New Deal first arose at the time of 2007-2008 financial crisis roughly simultaneously in the us and the UK. New York Times columnist Thomas Friedman wrote an article in January 2007 that suggested the approach. The same year the UK-based Green New Deal group formed, independently developing and publishing the first full proposal for a Green New Deal in July 2008. The group’s report laid out the architecture of the Green New Deal for the first time: combining reining in the power of big finance and transforming the way that government manages the economy with a plan to transform the economy and society to meet the challenges of climate change. The group also published several subsequent reports developing the idea over the following years. The Green New Deal was then taken up by the Green Party in the UK, by Green parties across Europe and by the United Nations Environment Programme. In 2018, the idea was revived by us senator Alexandria Ocasio-Cortez and the Sunrise Movement in the US following a meeting between a member of her team and UK Green New Deal group member Ann Pettifor. When AOC published a bill for the Green New Deal with Senator Edward Markey in February 2019 the idea caught on around the world.

Far from being some sort of a revolutionary, AOC was simply the latest person assigned to run with the agenda. While it is easy to mock the GND outright, it seems that elements of it are embedded within Agenda 2030 and the Great Reset.

8. UK PM Gordon Brown Promotes GND

Moving the UK to a low-carbon economy will create 400,000 new jobs over the next eight years, Gordon Brown has told a summit in London.
.
The prime minister called for an international “green new deal” to boost the environmental sector and help lift the global economy out of recession.
.
This will increase “confidence and certainty”, he added.
.
But unions and environmental groups called for more funding for green projects, along with better regulation.
The government has set a target of reducing greenhouse gas emissions by 80% from 1990 levels by 2050.

When he was Prime Minister of the UK, Gordon Brown openly called for a “Green New Deal” to rebuild the country after the banking collapse.

9. Green Quantitative Easing

As the Bank of England moves closer towards announcing an unprecedented third round of ‘Quantitative Easing’, experts are calling for this newly created money to be used more productively and effectively to achieve key social and environmental objectives. During the last round of Quantitative Easing (’QE’) the Bank of England purchased £275bn worth of government bonds with money it newly created. As the Bank of England prepares the ground to inject a likely £50bn to £75bn into the economy, the UK’s Green Party MP, Caroline Lucas, and Southampton University banking expert Professor Richard Werner, are calling for this money injection to be used for green projects that directly improve the environment and long-term quality of life, while creating many new jobs. Said Professor Richard A. Werner, Director of the Centre for Banking, Finance and Sustainable Development at the University of Southampton: “Many people would like money creation to be used to help the wider economy directly and to implement some badly needed green projects that would enhance the sustainability of the economy and improve the environment—as well as create new jobs.”

Green Quantitative Easing Paper

In 2012, Richard Werner submitted a proposal for “green quantitative easing”. In short, it would still involve printing off large sums of money. However, it would be spent on environmental causes, instead of being poured into banks.

10. GND Group UK Budget Submission

A Green New Deal Group briefing, The Green New Deal: Securing the Future, was sent to the Chancellor ahead of the March 2020 budget, with a letter signed by MPs from all the main opposition parties.

As the briefing, written by Green New Deal Group member Richard Murphy sets out, the Green New Deal Group have long argued that it is prudent for government to borrow (by issuing bonds) to invest in the transformation of our infrastructure and businesses while interest rates are low. The briefing shows how such government borrowing could be financed in a way that also creates a safe place for the nation’s pensions and savings, by making simple changes to existing tax incentives. Much of the £70bn saved annually in ISAs could then be invested in government-backed green bonds at an interest rate of 1.85% (the UK government’s current average cost of borrowing) and a quarter of the £100bn currently invested in pensions could be directed into Green New Deal investment.

A budget proposal was submitted to the UK Government in March 2020. It was written by the Green New Deal Group, and was able to get the signatures of many politicians.

11. Protests/Riots Partly Entirely For Show

In recent years, there have been loud environmental movements going on across the Western World. There have been efforts to shut down industries, pipelines, and society altogether. These people seem oblivious to the fact that shutting down oil (for example), would lead to a drastic reduction in their living standards.

However, this is a sleight of hand. Even though politicians appear to be turned off by the antics of violent protesters, they work behind the scenes to ensure that the goals are enacted anyway. Treaties such as Agenda 21, Agenda 2030, and the Great Reset are designed to achieve many of the same goals.

BOLD Like A Leopard wrote a great piece on some of the forces acting behind the scenes. It’s well worth the time to read.

Now we look at the bigger picture. While the public is distracted by very visible protests over environmental issues, just quietly implement them behind the scenes. People likely won’t notice. They are too focused on radicals who seem hell bent on destabilization, though those are distractions.

12. Bankers Run Climate Change Movement

This will seem a cruel twist, but central banks are heavily behind the green movement. One such group is the Network for Greening the Financial System, which currently boasts 75 members.

Hard to be part of the resistance when the financial sector supports, (or at least appears to support), green initiatives. It’s unclear, however, if the banks simply co-opted the movement, or whether they were always running things from behind the scenes.

CV #24(B): London School Of Hygiene & Tropical Medicine, More Modelling Financed By Gates

The London School Of Hygiene & Tropical Medicine gets substantial funding from the Bill & Melinda Gates Foundation, as does Imperial College London. And both have been funded to conduct computer modelling. Let’s dive in a bit deeper.

1. Other Articles On CV “Planned-emic”

The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes. The Gates Foundation finances many things, including, the World Health Organization, the Center for Disease Control, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the British Broadcasting Corporation, Sick Kids Hospital, and individual pharmaceutical companies. Worth mentioning: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations (IHR), that the WHO imposes are legally binding on all members.

2. Tax Filings Of B&M Gates Foundation

(Note: these are just a portion of the 2018 filings)

BILL & MELINDA GATES FOUNDATION
EIN: 56-2618866
gates.foundation.taxes.2016
gates.foundation.taxes.2017
gates.foundation.taxes.2018

3. Still Getting Money For Modelling

London School of Hygiene and Tropical Medicine
Date: September 2020
Purpose: to model the direct and indirect health and economic impacts of COVID-19 in LMICs
Amount: $166,059
Term: 11
Topic: Delivery of Solutions to Improve Global Health

Program: Global Development
Grantee Location: London
Grantee Website: http://www.lshtm.ac.uk/

Granted, the School of Hygiene and Tropical Medicine isn’t nearly as notorious as Imperial College London is at this point. However, Gates is still paying for computer modelling, so one has to wonder if the results are preplanned.

4. Earlier Gates Money For Modelling

London School of Hygiene and Tropical Medicine
Date: October 2016
Purpose: to maximize impact and accelerate development of new TB vaccines by creating and applying novel mathematical models to estimate the main target product profiles drivers for epidemiological impact of new TB vaccines
Amount: $193,437
Term: 39
Topic: Tuberculosis
Program: Global Health
Grantee Location: London
Grantee Website: http://www.lshtm.ac.uk/

The Gates Foundation also donated to some 2016 computer modelling. There are of course other grants over the years.

5. Centre for the Modelling of Infectious Diseases

The Centre for the Mathematical Modelling of Infectious Diseases (CMMID) at the London School of Hygiene & Tropical Medicine is a multidisciplinary grouping of epidemiologists, mathematicians, economists, statisticians and clinicians from across all three faculties of LSHTM.

That is the main team of researchers who are involved in the computer modelling (or guesswork), trying to determine how much viruses will spread.

6. Online Course: Intro To Modelling

Infectious diseases remain a leading cause of morbidity and mortality worldwide, with HIV, tuberculosis and malaria estimated to cause 10% of all deaths each year. New pathogens continue to emerge, as demonstrated by the SARS epidemic in 2003, the swine flu pandemic in 2009, MERS CoV in 2013, Zika in 2016 and recently, SARS-CoV-2.

Mathematical models are being increasingly used to understand the transmission of infections and to evaluate the potential impact of control programmes in reducing morbidity and mortality. Applications include determining optimal control strategies against new or emergent infections, such as SARS-CoV-2, Zika or Ebola, or against HIV, tuberculosis and malaria, and predicting the impact of vaccination strategies against common infections such as measles and rubella. Modelling was used extensively in the UK during the recent swine flu pandemic to monitor the extent of ongoing transmission and the potential impact of control such as school closures and vaccination. It is currently being used in many countries to predict the impact of interventions against COVID-19.

This two week online course, organised jointly between the London School of Hygiene & Tropical Medicine and Public Health England is intended to introduce professionals working on infectious diseases in either developing or developed countries to this exciting and expanding area. The emphasis will be on developing a conceptual understanding of the basic methods and on their practical application, rather than the manipulation of mathematical equations. The methods will be illustrated by “hands-on” experience of setting up models in spreadsheets as well as other specialist modelling packages, and seminars in which the applications of modelling will be discussed.

If you have 1,700 pounds to spare, then this modelling course may be for you. It’s an introduction into how computer modelling works to estimate growth and decay.

While it is true that computer modelling was used in Zika, Ebola and Swine Flu, that’s not really something to brag about. Just search “Neil Ferguson Imperial College London”.

The focus won’t be on manipulating mathematical equations? That’s good I guess.

7. Gates Very Well Known In LSHTM

A quick search of Bill Gates on the school’s website flags 143 articles. Gates, and his foundation, are well known and written about.

8. Models Aren’t Evidence Of Anything

This should be abundantly clear to all, but it is worth repeating. Models are just predictions, and limited by:

[1] The quality of the data coming in
[2] The understanding of how nature actually works
[3] The political agenda of the modeler

They are not proof or evidence, and should be given no weight when it comes to making complicated and expensive policy decisions.

We see time and time again that the information going in is garbage, and that the people doing the work have little to no grasp of what they are estimating. We also see too many politicians, bureaucrats, academics, and people in business who have their own agenda.

Don’t take any of these “predictions” at face value.